COMMUNITY HEALTHCARE TRUST I (CHCT) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:CHCT - US20369C1062 - REIT
15.29 USD
+0.08 (+0.53%)
15.29 USD
0 (0%)
We assign a fundamental rating of 3 out of 10 to CHCT. CHCT was compared to 128 industry peers in the Diversified REITs industry. Both the profitability and financial health of CHCT have multiple concerns. CHCT is valied quite expensively at the moment, while it does show a decent growth rate. Finally CHCT also has an excellent dividend rating.
1. Profitability
1.1 Basic Checks
In the past year CHCT has reported negative net income.
CHCT had a positive operating cash flow in the past year.
Of the past 5 years CHCT 4 years were profitable.
In the past 5 years CHCT always reported a positive cash flow from operatings.
1.2 Ratios
CHCT's Return On Assets of -1.06% is on the low side compared to the rest of the industry. CHCT is outperformed by 64.84% of its industry peers.
The Return On Equity of CHCT (-2.46%) is worse than 63.28% of its industry peers.
Looking at the Return On Invested Capital, with a value of 2.27%, CHCT is in line with its industry, outperforming 42.19% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CHCT is in line with the industry average of 3.06%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.06% | ||
| ROE | -2.46% | ||
| ROIC | 2.27% |
ROA(3y)0.71%
ROA(5y)1.48%
ROE(3y)1.2%
ROE(5y)2.39%
ROIC(3y)2.59%
ROIC(5y)2.93%
1.3 Margins
CHCT has a Operating Margin of 23.26%. This is comparable to the rest of the industry: CHCT outperforms 51.56% of its industry peers.
CHCT's Operating Margin has declined in the last couple of years.
CHCT has a Gross Margin of 80.68%. This is amongst the best in the industry. CHCT outperforms 80.47% of its industry peers.
In the last couple of years the Gross Margin of CHCT has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 23.26% | ||
| PM (TTM) | N/A | ||
| GM | 80.68% |
OM growth 3Y-9.56%
OM growth 5Y-2.62%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.21%
GM growth 5Y0.1%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CHCT is destroying value.
CHCT has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, CHCT has more shares outstanding
CHCT has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 0.77, we must say that CHCT is in the distress zone and has some risk of bankruptcy.
CHCT has a better Altman-Z score (0.77) than 67.19% of its industry peers.
A Debt/Equity ratio of 1.25 is on the high side and indicates that CHCT has dependencies on debt financing.
With a Debt to Equity ratio value of 1.25, CHCT perfoms like the industry average, outperforming 51.56% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.25 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.77 |
ROIC/WACC0.34
WACC6.72%
2.3 Liquidity
A Current Ratio of 0.47 indicates that CHCT may have some problems paying its short term obligations.
CHCT's Current ratio of 0.47 is on the low side compared to the rest of the industry. CHCT is outperformed by 82.81% of its industry peers.
CHCT has a Quick Ratio of 0.47. This is a bad value and indicates that CHCT is not financially healthy enough and could expect problems in meeting its short term obligations.
CHCT's Quick ratio of 0.16 is on the low side compared to the rest of the industry. CHCT is outperformed by 92.97% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.47 | ||
| Quick Ratio | 0.16 |
3. Growth
3.1 Past
The earnings per share for CHCT have decreased strongly by -146.88% in the last year.
CHCT shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -10.22% yearly.
The Revenue for CHCT has decreased by -17.52% in the past year. This is quite bad
Measured over the past years, CHCT shows a quite strong growth in Revenue. The Revenue has been growing by 13.73% on average per year.
EPS 1Y (TTM)-146.88%
EPS 3Y-37.5%
EPS 5Y-10.22%
EPS Q2Q%-25%
Revenue 1Y (TTM)-17.52%
Revenue growth 3Y8.53%
Revenue growth 5Y13.73%
Sales Q2Q%4.88%
3.2 Future
Based on estimates for the next years, CHCT will show a very strong growth in Earnings Per Share. The EPS will grow by 37.91% on average per year.
Based on estimates for the next years, CHCT will show a quite strong growth in Revenue. The Revenue will grow by 9.35% on average per year.
EPS Next Y-216.57%
EPS Next 2Y47.84%
EPS Next 3Y37.91%
EPS Next 5YN/A
Revenue Next Year4.49%
Revenue Next 2Y5.29%
Revenue Next 3Y6.02%
Revenue Next 5Y9.35%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for CHCT. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 33.31, the valuation of CHCT can be described as expensive.
Based on the Price/Forward Earnings ratio, CHCT is valued a bit cheaper than the industry average as 73.44% of the companies are valued more expensively.
CHCT is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 36.10, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 33.31 |
4.2 Price Multiples
CHCT's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CHCT is cheaper than 60.94% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 13.5 |
4.3 Compensation for Growth
A more expensive valuation may be justified as CHCT's earnings are expected to grow with 37.91% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y47.84%
EPS Next 3Y37.91%
5. Dividend
5.1 Amount
CHCT has a Yearly Dividend Yield of 11.96%, which is a nice return.
CHCT's Dividend Yield is rather good when compared to the industry average which is at 6.58. CHCT pays more dividend than 98.44% of the companies in the same industry.
CHCT's Dividend Yield is rather good when compared to the S&P500 average which is at 2.32.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 11.96% |
5.2 History
The dividend of CHCT has a limited annual growth rate of 2.99%.
CHCT has been paying a dividend for at least 10 years, so it has a reliable track record.
As CHCT did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)2.99%
Div Incr Years9
Div Non Decr Years9
5.3 Sustainability
CHCT has negative earnings and hence a negative payout ratio. The dividend may be in danger.
CHCT's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-507.68%
EPS Next 2Y47.84%
EPS Next 3Y37.91%
15.29
+0.08 (+0.53%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)
Earnings (Next)
Inst Owners84.9%
Inst Owner Change-3.3%
Ins Owners5.9%
Ins Owner Change4.1%
Market Cap435.31M
Revenue(TTM)119.55M
Net Income(TTM)-10.49M
Analysts81.82
Price Target18.26 (19.42%)
Short Float %3.76%
Short Ratio3.65
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 11.96% |
Yearly Dividend1.85
Dividend Growth(5Y)2.99%
DP-507.68%
Div Incr Years9
Div Non Decr Years9
Ex-Date
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-75.89%
Min EPS beat(2)-88.54%
Max EPS beat(2)-63.24%
EPS beat(4)0
Avg EPS beat(4)-63.43%
Min EPS beat(4)-88.54%
Max EPS beat(4)-43.98%
EPS beat(8)0
Avg EPS beat(8)-53.34%
EPS beat(12)1
Avg EPS beat(12)-60.44%
EPS beat(16)1
Avg EPS beat(16)-48.6%
Revenue beat(2)0
Avg Revenue beat(2)-1.38%
Min Revenue beat(2)-2.49%
Max Revenue beat(2)-0.28%
Revenue beat(4)0
Avg Revenue beat(4)-1.73%
Min Revenue beat(4)-3.64%
Max Revenue beat(4)-0.28%
Revenue beat(8)0
Avg Revenue beat(8)-3.34%
Revenue beat(12)1
Avg Revenue beat(12)-2.84%
Revenue beat(16)1
Avg Revenue beat(16)-2.68%
PT rev (1m)-6.28%
PT rev (3m)-6.28%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0.63%
Revenue NQ rev (3m)-0.67%
Revenue NY rev (1m)-0.01%
Revenue NY rev (3m)-0.65%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 33.31 | ||
| P/S | 3.64 | ||
| P/FCF | N/A | ||
| P/OCF | 7.69 | ||
| P/B | 1.02 | ||
| P/tB | 1.02 | ||
| EV/EBITDA | 13.5 |
EPS(TTM)-0.15
EYN/A
EPS(NY)0.46
Fwd EY3%
FCF(TTM)-0.24
FCFYN/A
OCF(TTM)1.99
OCFY13%
SpS4.2
BVpS14.99
TBVpS14.94
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.06% | ||
| ROE | -2.46% | ||
| ROCE | 2.88% | ||
| ROIC | 2.27% | ||
| ROICexc | 2.28% | ||
| ROICexgc | 2.32% | ||
| OM | 23.26% | ||
| PM (TTM) | N/A | ||
| GM | 80.68% | ||
| FCFM | N/A |
ROA(3y)0.71%
ROA(5y)1.48%
ROE(3y)1.2%
ROE(5y)2.39%
ROIC(3y)2.59%
ROIC(5y)2.93%
ROICexc(3y)2.61%
ROICexc(5y)2.94%
ROICexgc(3y)2.69%
ROICexgc(5y)3%
ROCE(3y)3.28%
ROCE(5y)3.7%
ROICexgc growth 3Y-9.66%
ROICexgc growth 5Y-0.75%
ROICexc growth 3Y-10.19%
ROICexc growth 5Y-1.2%
OM growth 3Y-9.56%
OM growth 5Y-2.62%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.21%
GM growth 5Y0.1%
F-Score3
Asset Turnover0.12
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.25 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 7.48 | ||
| Cap/Depr | 145.76% | ||
| Cap/Sales | 53.07% | ||
| Interest Coverage | 1.1 | ||
| Cash Conversion | 79.35% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.47 | ||
| Quick Ratio | 0.16 | ||
| Altman-Z | 0.77 |
F-Score3
WACC6.72%
ROIC/WACC0.34
Cap/Depr(3y)284.94%
Cap/Depr(5y)339.12%
Cap/Sales(3y)99.29%
Cap/Sales(5y)115.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-146.88%
EPS 3Y-37.5%
EPS 5Y-10.22%
EPS Q2Q%-25%
EPS Next Y-216.57%
EPS Next 2Y47.84%
EPS Next 3Y37.91%
EPS Next 5YN/A
Revenue 1Y (TTM)-17.52%
Revenue growth 3Y8.53%
Revenue growth 5Y13.73%
Sales Q2Q%4.88%
Revenue Next Year4.49%
Revenue Next 2Y5.29%
Revenue Next 3Y6.02%
Revenue Next 5Y9.35%
EBIT growth 1Y-32.49%
EBIT growth 3Y-1.85%
EBIT growth 5Y10.76%
EBIT Next Year263.34%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y92.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-9.45%
OCF growth 3Y1.48%
OCF growth 5Y12.72%
COMMUNITY HEALTHCARE TRUST I / CHCT FAQ
What is the fundamental rating for CHCT stock?
ChartMill assigns a fundamental rating of 3 / 10 to CHCT.
What is the valuation status of COMMUNITY HEALTHCARE TRUST I (CHCT) stock?
ChartMill assigns a valuation rating of 2 / 10 to COMMUNITY HEALTHCARE TRUST I (CHCT). This can be considered as Overvalued.
How profitable is COMMUNITY HEALTHCARE TRUST I (CHCT) stock?
COMMUNITY HEALTHCARE TRUST I (CHCT) has a profitability rating of 3 / 10.
What is the expected EPS growth for COMMUNITY HEALTHCARE TRUST I (CHCT) stock?
The Earnings per Share (EPS) of COMMUNITY HEALTHCARE TRUST I (CHCT) is expected to decline by -216.57% in the next year.